pegcetacoplan
sobi,Apellis Pharmaceuticals
['sobi']
$apls apellis and sobi report new data reinforcing the robust efficacy and safety profile of empaveli (pegcetacoplan) for pnh at eha 2022 congress 
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft